GUTS
Price
$0.96
Change
-$0.00 (-0.00%)
Updated
Aug 11, 03:14 PM (EDT)
Capitalization
47.09M
One day until earnings call
MOLN
Price
$3.45
Change
-$0.21 (-5.74%)
Updated
Aug 8, 10:30 AM (EDT)
Capitalization
134.53M
14 days until earnings call
Interact to see
Advertisement

GUTS vs MOLN

Header iconGUTS vs MOLN Comparison
Open Charts GUTS vs MOLNBanner chart's image
Fractyl Health
Price$0.96
Change-$0.00 (-0.00%)
Volume$120
Capitalization47.09M
Molecular Partners AG
Price$3.45
Change-$0.21 (-5.74%)
VolumeN/A
Capitalization134.53M
GUTS vs MOLN Comparison Chart in %
Loading...
GUTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MOLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GUTS vs. MOLN commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GUTS is a Hold and MOLN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (GUTS: $0.96 vs. MOLN: $3.66)
Brand notoriety: GUTS and MOLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GUTS: 113% vs. MOLN: 81%
Market capitalization -- GUTS: $47.09M vs. MOLN: $134.53M
GUTS [@Biotechnology] is valued at $47.09M. MOLN’s [@Biotechnology] market capitalization is $134.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GUTS’s FA Score shows that 0 FA rating(s) are green whileMOLN’s FA Score has 1 green FA rating(s).

  • GUTS’s FA Score: 0 green, 5 red.
  • MOLN’s FA Score: 1 green, 4 red.
According to our system of comparison, MOLN is a better buy in the long-term than GUTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GUTS’s TA Score shows that 4 TA indicator(s) are bullish while MOLN’s TA Score has 4 bullish TA indicator(s).

  • GUTS’s TA Score: 4 bullish, 6 bearish.
  • MOLN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, MOLN is a better buy in the short-term than GUTS.

Price Growth

GUTS (@Biotechnology) experienced а -46.88% price change this week, while MOLN (@Biotechnology) price change was +3.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.72%. For the same industry, the average monthly price growth was +32.20%, and the average quarterly price growth was +19.30%.

Reported Earning Dates

GUTS is expected to report earnings on Aug 12, 2025.

MOLN is expected to report earnings on Aug 25, 2025.

Industries' Descriptions

@Biotechnology (+22.72% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MOLN($135M) has a higher market cap than GUTS($47.1M). MOLN YTD gains are higher at: -22.810 vs. GUTS (-53.330). MOLN has higher annual earnings (EBITDA): -57.15M vs. GUTS (-95.83M). MOLN has more cash in the bank: 131M vs. GUTS (42.1M). MOLN has less debt than GUTS: MOLN (2.14M) vs GUTS (61.4M). MOLN has higher revenues than GUTS: MOLN (2.23M) vs GUTS (60K).
GUTSMOLNGUTS / MOLN
Capitalization47.1M135M35%
EBITDA-95.83M-57.15M168%
Gain YTD-53.330-22.810234%
P/E RatioN/AN/A-
Revenue60K2.23M3%
Total Cash42.1M131M32%
Total Debt61.4M2.14M2,868%
TECHNICAL ANALYSIS
Technical Analysis
GUTSMOLN
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
78%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
69%
Advances
ODDS (%)
Bullish Trend 15 days ago
83%
Bullish Trend 14 days ago
68%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 11 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
GUTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MOLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EXLS42.200.14
+0.33%
ExlService Holdings
MLKN19.920.06
+0.30%
MillerKnoll
ATMV11.910.01
+0.10%
AlphaVest Acquisition Corp
SFOSF2.30N/A
N/A
Shanghai Fosun Pharmaceutical Group Co Ltd
OCGN1.00N/A
-0.16%
Ocugen

GUTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GUTS has been loosely correlated with MNKD. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if GUTS jumps, then MNKD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GUTS
1D Price
Change %
GUTS100%
-1.16%
MNKD - GUTS
37%
Loosely correlated
+2.62%
IPSC - GUTS
35%
Loosely correlated
-4.14%
GLUE - GUTS
34%
Loosely correlated
+3.55%
SCPH - GUTS
32%
Poorly correlated
-7.58%
RCKT - GUTS
32%
Poorly correlated
N/A
More

MOLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MOLN has been loosely correlated with SNSE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if MOLN jumps, then SNSE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MOLN
1D Price
Change %
MOLN100%
N/A
SNSE - MOLN
42%
Loosely correlated
+6.10%
ATRA - MOLN
34%
Loosely correlated
-0.05%
HURA - MOLN
30%
Poorly correlated
-5.35%
GRI - MOLN
30%
Poorly correlated
+0.80%
GUTS - MOLN
29%
Poorly correlated
-1.16%
More